Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids

American Journal of Pathology

Volumn 158, Issue 5, 2001, Pages 1803-1808

  Kytölä, Soili ^a,b   Höög, Anders ^a   Nord, Brita ^a   Cedermark, Björn ^a   Frisk, Tony ^a   Larsson, Catharina ^a   Kjellman, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CARCINOID; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME 18Q; CHROMOSOME 4P; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE INACTIVATION; HUMAN; MALE; METASTASIS; MIDGUT; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0035004835     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64136-3     Document Type: Article

References (33)

1. An analysis of 8305 cases of carcinoid tumors
2. Carcinoid tumours: Frequency in a defined population during a 12-year period
3. The endocrine digestive system
4. Carcinoids associated with multiple endocrine neoplasia syndromes
5. Positional cloning of the gene for multiple endocrine neoplasia-type 1
6. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene
7. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11
8. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
9. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis
10. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization
11. Genetic changes in the spectrum of neuroendocrine lung tumors
12. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): Marked differences indicating diversity in molecular pathogenesis
13. Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system
14. TP53 tumor suppressor gene: A model for investigating human mutagenesis
15. In frequent mutations of the p53 gene in pulmonary carcinoid tumors
16. Identification of p53 gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotoic SSCA
17. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors
18. DNA copy number losses in human neoplasms
19. The DCC gene: Structural analysis and mutations in colorectal carcinomas
20. Allelotype of pancreatic adenocarcinoma using a xenograft model
21. DCC: Linking tumor suppressor genes and altered cell surface interactions in cancer?
22. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
23. Somatic alterations of the Smad-2 gene in human colorectal cancers
24. Alterations of the PPP2R1B gene in human lung and colon cancer
25. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
26. Cancer risk and the ATM gene: A continuing debate
27. Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through Cdc25
28. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23
29. A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23
30. Involvement of the ALL-1 gene in a solid tumor
31. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix
32. Genetic changes in adrenocortical tumors detected by comparative genomic hybridization correlate with tumor size and malignancy
33. Comparative genomic hybridization reveals a specific patter of chromosomal gains and losses during the genesis of colorectal tumors